...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Endoscopy International Open >Outcomes of EUS-guided choledochoduodenostomy as primary drainage for distal biliary obstruction with covered self-expandable metallic stents
【24h】

Outcomes of EUS-guided choledochoduodenostomy as primary drainage for distal biliary obstruction with covered self-expandable metallic stents

机译：EUS引导的胆固色植物术的结果作为覆盖自膨胀金属支架的远端胆道阻塞的主要引流

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background and study aims?Endoscopic ultrasonography-guided choledochoduodenostomy (EUS-CDS) is an alternative therapy for percutaneous transhepatic biliary drainage. Outcomes of EUS-CDS for distal biliary tract obstruction with a covered self-expandable metallic stent (SEMS) as a primary drainage technique are unclear because there are few relevant reports. This study aimed to determine outcomes in patients undergoing EUS-CDS using SEMS as the primary drainage technique for malignant distal biliary duct obstruction. Patients and methods?This retrospective study was conducted at Aichi Cancer Center Hospital, from January 2010 to July 2018, using data from our database. Results?EUS-CDS was performed as a primary drainage technique for 92 patients. The technical success rate was 92.8?%, and the clinical success rate was 91.6?%. The overall incidence of adverse events was 15.7?%. The median stent patency time for the EUS-CDS was 396 days. Nineteen patients required re-intervention because of cholangitis or jaundice. Conclusion?EUS-CDS as a primary drainage technique using SEMS has high technical and clinical success rates. It should be considered an effective drainage method with respect to long-term stent patency, low re-intervention rates, and absence of severe complications.
机译：背景和研究旨在？内窥镜超声引导的胆管胆蛋白酶（EUS-CDS）是经皮转发胆道引流的替代疗法。由于主要排水技术，具有覆盖的自膨胀金属支架（SEMS）的远端胆道阻塞的EUS-CD的结果尚不清楚，因为有很少的相关报告。该研究旨在使用SEMS作为恶性远端胆管阻塞的初级排水技术确定eUS-CD患者的结果。患者和方法？该回顾性研究于2010年1月至2018年7月，在2010年1月到2018年7月，使用来自我们的数据库的数据进行的。结果？EUS-CDS作为92名患者的主要排水技术进行。技术成功率为92.8？％，临床成功率为91.6？％。不良事件的总发生率为15.7？％。 EUS-CD的中位态支架通畅时间为396天。 19名患者因胆管炎或黄疸而需要重新干预。结论？EUS-CD作为使用SEM的主要排水技术具有高技术和临床成功率。它应该被认为是关于长期支架通畅，低再干预率和没有严重并发症的有效排水方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号